SCHEMBL12050635

SCHEMBL12050635

CN1C(=O)NC(=O)C12Cc1cc3nc(-c4nc(-c5ccccc5)cs4)[nH]c3cc1C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ TP53 P04637 2/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ ALOX15 P16050 2/20 0.51
▸ BRCA1 P38398 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ CALCRL Q16602 10/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.42
▸ CALCA P06881 2/20 0.40
▸ KIT P10721 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12050642 0.93 CALCRL (0.45) KDM4EKMT2AMEN1ALDH1A1TP53
SCHEMBL12050633 0.84 CALCRL (0.50) KDM4EALDH1A1TP53CYP3A4HPGD
SCHEMBL12990719 0.76 KDM4E (0.47) KDM4EKMT2AMEN1ALDH1A1TP53
SCHEMBL12050621 0.76 CALCRL (0.45) CALCRLCALCA
SCHEMBL14535761 0.75 NPBWR1 (0.42) KDM4EKMT2AMEN1ALDH1A1TP53
SCHEMBL12050623 0.74 CALCRL (0.47) CALCRLCALCA
SCHEMBL32665694 0.73 KDM4E (0.69) KDM4EKMT2AMEN1ALDH1A1TP53
SCHEMBL12050634 0.73 CALCRL (0.48) KMT2AMEN1ALDH1A1HPGDHSD17B10
SCHEMBL12050622 0.73 CALCRL (0.49) KDM4EKMT2AMEN1ALDH1A1HPGD
SCHEMBL3391601 0.73 DGAT1 (0.53) KDM4EKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-8071770-B2 Spirohydantoin aryl CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2011-12-06 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2009-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239870-A1 Spirohydantoin Aryl Cgrp Receptor Antagonists BDKRB1, BDKRB2, CALCRL KDM4E 4171/4885KMT2A 4002/4885MEN1 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback